
Work Here?
Magnify provides an AI-powered platform for post-sales orchestration and customer growth automation, designed for software companies. The platform helps Customer Success, Product, and Revenue teams manage the customer lifecycle at scale by turning data from systems like Salesforce, Gainsight, Pendo, and Snowflake into actionable insights. It uses AI and machine learning to identify what drives churn and expansion, then automatically delivers personalized engagement through emails and in-app messages. This no-code tool lets teams build and automate workflows that connect to existing enterprise systems, reducing manual work and letting teams focus on higher-value tasks. Magnify differentiates itself by creating a distinct category called “Customer Growth Automation,” emphasizing end-to-end lifecycle orchestration across multiple tools rather than building a single-point solution. Its goal is to increase product adoption, cut churn, and grow revenue for enterprise software customers.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Company Size
11-50
Company Stage
Early VC
Total Funding
$12M
Headquarters
Seattle, Washington
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$12M
Above
Industry Average
Funded Over
2 Rounds
Health Insurance
Dental Insurance
Vision Insurance
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Paid Vacation
Paid Holidays
401(k) Company Match
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend
Conference Attendance Budget
Professional Development Budget
Stock Options
Company Equity
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Parental Leave
Relocation Assistance
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Education allowance
Gym Membership
Commuter Benefits
Meal Benefits
Legal Services
Employee Discounts
Employee Referral Bonus
Bereavement Leave
Vacation/Leave
To address this issue, Magnify, which bills itself as a customer growth optimization platform focused on post-sales optimization, has launched its new AI Assistant, an agent purpose-built to optimize key elements of post-sales revenue generation.
That's why Magnify is excited to launch the Customer Growth Automation (CGA) Maturity Model - a four-phase framework designed to help B2B companies baseline their current approach and identify what's needed to scale retention, renewals, and expansion more efficiently.
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Conroy. (Adaptive Biotech Photo)— Seattle biotech company Adaptive Biotechnologies Corp. disclosed in a SEC filing that Kevin Conroy has stepped down from his position as board member.Adaptive announced Conroy’s appointment to its board in May 2019 as it was gearing up for its initial public offering. The company said his departure was voluntary and not a result of any disagreement with its operations, policies or practices.Conroy is the chairman and CEO of Exact Sciences, a publicly traded molecular diagnostics company that focuses on the detection of early-stage cancers. The Madison, Wis.-based firm reported more than $2 billion in revenue last year.The resignation comes after Adaptive board member Leslie Trigg voluntarily resigned in June.— David Meininger confirmed to GeekWire he stepped down from his role as CEO of Link Immunotherapeutics, a Seattle-based company that focuses on developing new immuno-oncology drugs
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Conroy. (Adaptive Biotech Photo)— Seattle biotech company Adaptive Biotechnologies Corp. disclosed in a SEC filing that Kevin Conroy has stepped down from his position as board member.Adaptive announced Conroy’s appointment to its board in May 2019 as it was gearing up for its initial public offering. The company said his departure was voluntary and not a result of any disagreement with its operations, policies or practices.Conroy is the chairman and CEO of Exact Sciences, a publicly traded molecular diagnostics company that focuses on the detection of early-stage cancers. The Madison, Wis.-based firm reported more than $2 billion in revenue last year.The resignation comes after Adaptive board member Leslie Trigg voluntarily resigned in June.— David Meininger confirmed to GeekWire he stepped down from his role as CEO of Link Immunotherapeutics, a Seattle-based company that focuses on developing new immuno-oncology drugs
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Company Size
11-50
Company Stage
Early VC
Total Funding
$12M
Headquarters
Seattle, Washington
Founded
2021
Find jobs on Simplify and start your career today